These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23042423)

  • 21. Utilizing brain imaging for analgesic drug development.
    Borsook D; Ploghaus A; Becerra L
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1342-7. PubMed ID: 12498011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychotropic adjuvant analgesics for pain in cancer and AIDS.
    Breitbart W
    Psychooncology; 1998; 7(4):333-45. PubMed ID: 9741072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of genomics in clinical trial design.
    Simon R
    Clin Cancer Res; 2008 Oct; 14(19):5984-93. PubMed ID: 18829477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tapentadol hydrochloride: a centrally acting oral analgesic.
    Wade WE; Spruill WJ
    Clin Ther; 2009 Dec; 31(12):2804-18. PubMed ID: 20110020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The rise and fall of the dolorimeter: pain, analgesics, and the management of subjectivity in mid-twentieth-century United States.
    Tousignant N
    J Hist Med Allied Sci; 2011 Apr; 66(2):145-79. PubMed ID: 20423981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analgesic efficacy and the tolerance for piroxicam-beta-cyclodextrin compared to piroxicam, paracetamol and placebo in the treatment of postextraction dental pain].
    Dolci G; Ripari M; Pacifici L; Umile A
    Minerva Stomatol; 1993 May; 42(5):235-41. PubMed ID: 8413108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A paradigm shift in tumour response evaluation of targeted therapy: the assessment of novel drugs in exploratory clinical trials.
    Cousin S; Taieb S; Penel N
    Curr Opin Oncol; 2012 May; 24(3):338-44. PubMed ID: 22418613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Enkephalin catabolism inhibitors and antalgics of the future: from preclinical research to clinical trials].
    Noble F; Fournié-Zaluski MC; Roques BP
    Therapie; 1999; 54(1):121-33. PubMed ID: 10216436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and conduct of phase II studies of targeted anticancer therapy: recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT).
    Booth CM; Calvert AH; Giaccone G; Lobbezoo MW; Eisenhauer EA; Seymour LK
    Eur J Cancer; 2008 Jan; 44(1):25-9. PubMed ID: 17845846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced formulation design: improving drug therapies for the management of severe and chronic pain.
    Miller DA; Dinunzio JC; Williams RO
    Drug Dev Ind Pharm; 2008 Feb; 34(2):117-33. PubMed ID: 18302030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations.
    Cooper SA; Desjardins PJ; Turk DC; Dworkin RH; Katz NP; Kehlet H; Ballantyne JC; Burke LB; Carragee E; Cowan P; Croll S; Dionne RA; Farrar JT; Gilron I; Gordon DB; Iyengar S; Jay GW; Kalso EA; Kerns RD; McDermott MP; Raja SN; Rappaport BA; Rauschkolb C; Royal MA; Segerdahl M; Stauffer JW; Todd KH; Vanhove GF; Wallace MS; West C; White RE; Wu C
    Pain; 2016 Feb; 157(2):288-301. PubMed ID: 26683233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase 0 Clinical Trial Strategies for the Neurosurgical Oncologist.
    Sanai N
    Neurosurgery; 2019 Dec; 85(6):E967-E974. PubMed ID: 31245813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Problems in publication of clinical trial methodology.
    Lasagna L
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):751-3. PubMed ID: 373967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Discovery and clinical development of targeted molecular therapeutics].
    Kimura S
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():12-7. PubMed ID: 23513804
    [No Abstract]   [Full Text] [Related]  

  • 35. [III. Development of molecular targeting therapy to musculoskeletal tumor].
    Ueda T
    Gan To Kagaku Ryoho; 2013 Mar; 40(3):318-21. PubMed ID: 23560333
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel clinical trial designs for targeted therapies
.
    Hsu Schmitz SF
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):695-697. PubMed ID: 28655382
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental observations on Haffner's method for testing analgesic drugs.
    BIANCHI C; FRANCESCHINI J
    Br J Pharmacol Chemother; 1954 Sep; 9(3):280-4. PubMed ID: 13199245
    [No Abstract]   [Full Text] [Related]  

  • 38. Planning a cross-over trial.
    Lancet; 1979 Sep; 2(8141):511. PubMed ID: 90224
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of a discriminant function in the assessment of analgesic drugs.
    Hill GB; Loan W; Dundee JW
    Clin Pharmacol Ther; 1967; 8(4):543-7. PubMed ID: 4951969
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical trial of 10820, a new synthetic analgesic.
    BERCEL NA
    Dis Nerv Syst; 1947 Jan; 9(1):15-8. PubMed ID: 18918196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.